Funder: American Association for Cancer Research
Due Dates: Currently unavailable (check program page for updates)
Funding Amounts: Award size and duration not specified; typically supports research projects with substantial funding for early-career and established investigators
Summary: Supports research to develop innovative approaches for overcoming resistance in lung cancer treatments.
Key Information: Focus is on ALK-positive and treatment-resistant non-small cell lung cancer mechanisms and therapies.